Loading...
DRI Healthcare Trust
DHT-UN.TO•TSX
HealthcareDrug Manufacturers - Specialty & Generic
CA$12.96
CA$-0.03(-0.23%)
DRI Healthcare Trust (DHT-UN.TO) Stock Overview
Explore DRI Healthcare Trust’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
17.97%
↑ 17.97%
Profit Growth
CA$-0.08
↓ 103.68%
EPS Growth
CA$-0.08
↓ 102.88%
Operating Margin
-14.83%
↓ 118.08%
ROE
-0.57%
↓ 103.68%
Dividend Yield
0.00%
↓ 18.84%
Analyst Recommendations data is not available for DHT-UN.TOAnalyst Recommendations details for DHT-UN.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
CEO
Mr. Behzad Khosrowshahi CPA
Employees
36
Headquarters
1 First Canadian Place, Toronto, ON
Founded
2021